-
Company Insights
New![]()
Innovation and Patenting activity of Perseus Mining Ltd Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Perseus Mining Ltd Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
New![]()
Sissingue Project
The Sissingue Project is a gold mine in Ivory Coast. It is currently in operation. Empower your strategies with our Sissingue Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital...
-
Product Insights
New![]()
Yaoure Mine
The Yaoure Mine is a gold mine in Ivory Coast. It is currently in operation. Empower your strategies with our Yaoure Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital...
-
Product Insights
New![]()
Edikan Gold Mine
The Edikan Gold Mine is a gold mine in Ghana. It is currently in operation. Empower your strategies with our Edikan Gold Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CKR-051 in Wounds
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.CKR-051 in WoundsDrug Details:Peptide is under development for the treatment of hair loss, diabetic foot ulcer...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CX-904 in Colorectal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.CX-904 in Colorectal Cancer Drug Details:CX-904 is under development for the treatment of solid tumors and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TBA-7371 in Pulmonary Tuberculosis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.TBA-7371 in Pulmonary Tuberculosis Drug Details:TBA-7371 is under development for the treatment of pulmonary tuberculosis caused...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TAS-2940 in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TAS-2940 in Solid TumorDrug Details:TAS-2940 is under development for the treatment of locally advanced and metastatic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Allergen For Grass Pollen Allergy in Grass Pollen Allergy
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Allergen For Grass Pollen Allergy in Grass Pollen Allergy Drug Details: Allergen extract was...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TAS-2940 in Recurrent Glioblastoma Multiforme (GBM)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TAS-2940 in Recurrent Glioblastoma Multiforme (GBM)Drug Details:TAS-2940 is under development for the treatment of locally advanced...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.